AccessPak for HIV PEP Basic and Kadcyla

• Generic Name: emtricitabine / tenofovir
• Dosage Forms: n.a.
• Other Brand Names: AccessPak for HIV PEP Basic, Descovy, Truvada

AccessPak for HIV PEP Basic are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body.

AccessPak for HIV PEP Basic is a combination medicine used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). AccessPak for HIV PEP Basic is not a cure for HIV or AIDS, but it can be used to treat HIV in adults and children who are at least 12 years old and weigh at least 17 kilograms (37 pounds).

AccessPak for HIV PEP Basic is also used in children who weigh between 55 and 77 pounds (25 to 35 kilograms) and who take certain other HIV medications.

Truvada PrEP is used together with safer-sex practices to reduce the risk of becoming infected with HIV. You must be HIV-negative and an adult to use Truvada PrEP for this purpose.

AccessPak for HIV PEP Basic may also be used for purposes not listed in this medication guide.

• Generic Name: ado-trastuzumab emtansine
• Dosage Forms: injection, powder, lyophilized, for solution
• Other Brand Names: Kadcyla

Kadcyla (ado-trastuzumab emtansine) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Kadcyla is used to treat HER2-positive breast cancer.

Kadcyla is used both for early breast cancer and for breast cancer that has spread to other parts of the body (metastatic).

Kadcyla is usually given after other cancer medications have been tried without success.

Kadcyla should not be used in place of Herceptin (trastuzumab).